These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5072414)

  • 1. GLC determination of erythromycin in enteric-coated tablets.
    Robertson JH; Tsuji K
    J Pharm Sci; 1972 Oct; 61(10):1633-5. PubMed ID: 5072414
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography.
    Wardrop J; Ficker D; Franklin S; Gorski RJ
    J Pharm Sci; 2000 Sep; 89(9):1097-105. PubMed ID: 10944374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved high-pressure liquid chromatographic method for the analysis of erythromycin in solid dosage forms.
    Tsuji K; Kane MP
    J Pharm Sci; 1982 Oct; 71(10):1160-4. PubMed ID: 7143216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of acid protective coating on absorption of erythromycin at oral administration].
    Koroleva VG; Belozerova OP; Vasil'ev VK; Stepnaia VE
    Antibiotiki; 1969 Dec; 14(12):1084-8. PubMed ID: 5371175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stability of erythromycin stearate in coated tablets during the action of gastric juice in vitro].
    Pospísilová B; Kubes J
    Cesk Farm; 1987 Mar; 36(2):67-72. PubMed ID: 3581192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H; Oschmann R
    Pharmazie; 1987 Dec; 42(12):832-6. PubMed ID: 3444845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GC determination of long chain fatty acids that compose D003 in 5-mg film-coated tablets.
    Méndez Antolín E; Marrero Delange D; González Canavaciolo V; Laguna Granja A
    J Pharm Biomed Anal; 2003 Mar; 31(4):613-20. PubMed ID: 12644187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin--a national survey V: Determination of aspirin and impurities in enteric coated tablets and suppository formulations and in vitro dissolution of enteric coated tablets.
    Kirchhoefer RD; Jefferson E; Flinn PE
    J Pharm Sci; 1982 Sep; 71(9):1049-52. PubMed ID: 7131273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid inactivation of erythromycin stearate in solid dosage forms.
    Boggiano BG; Gleeson M
    J Pharm Sci; 1976 Apr; 65(4):497-502. PubMed ID: 5588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a gas chromatographic method for determining fatty acids that compose D003 in 10 mg film-coated tablets.
    Antolín EM; Marrero Delange D; González Canavaciolo V; Tejeda Díaz Y; Sierra Pérez R; Cora Medina M
    Farmaco; 2004 Jul; 59(7):543-7. PubMed ID: 15231430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of erythromycin and its derivatives by gas-liquid chromatography.
    Tsuji K; Robertson JH
    Anal Chem; 1971 Jun; 43(7):818-21. PubMed ID: 5576603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood concentration and urinary excretion in human of OE-7, a gastric hard capsule containing enteric-coated granules. I (author's transl)].
    Yamashita T; Tsubura E; Fukuda T
    Jpn J Antibiot; 1976 Feb; 29(2):201-6. PubMed ID: 1263346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris.
    Bleeker J
    J Int Med Res; 1983; 11(1):38-41. PubMed ID: 6219902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lacquered tablets and film dragees].
    Hess H; Janssen HJ
    Pharm Acta Helv; 1969 Oct; 44(10):581-601. PubMed ID: 4901296
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enteric coating].
    Delporte JP
    Pharm Acta Helv; 1970 Sep; 45(9):525-52. PubMed ID: 4918879
    [No Abstract]   [Full Text] [Related]  

  • 17. Semiautomated assay for the simultaneous determination of propoxyphene hydrochloride and paramethasone acetate in coated single tablets.
    Stevenson CE; Comer I
    J Pharm Sci; 1968 Jul; 57(7):1227-30. PubMed ID: 5662069
    [No Abstract]   [Full Text] [Related]  

  • 18. The permeability of enteric coatings and the dissolution rates of coated tablets.
    Porter SC; Ridgway K
    J Pharm Pharmacol; 1982 Jan; 34(1):5-8. PubMed ID: 6121034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and stability of erythromycin delayed release tablets.
    Ogwal S; Xide TU
    Afr Health Sci; 2001 Dec; 1(2):90-6. PubMed ID: 12789122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Release of erythromycin from enteric-coated tablets].
    Chałasińska B; Zakrewski Z
    Acta Pol Pharm; 1985; 42(1):61-7. PubMed ID: 4013800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.